Lymphomatoid granulomatosis developing from chronic active Epstein–Barr virus infection in a patient with myelodysplastic syndrome
Ai Mihara
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorTsunayuki Kakimoto
Department of Hematology, Sumitomo Hospital, Osaka, Japan
Search for more papers by this authorKazuhito Suzuki
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorYukinari Sanada
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorMichio Iwabuchi
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorYoshinobu Aisa
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorSachiko Yoshida
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorTomonori Nakazato
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorAi Mihara
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorTsunayuki Kakimoto
Department of Hematology, Sumitomo Hospital, Osaka, Japan
Search for more papers by this authorKazuhito Suzuki
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorYukinari Sanada
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorMichio Iwabuchi
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorYoshinobu Aisa
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorSachiko Yoshida
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this authorTomonori Nakazato
Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Kanagawa
Search for more papers by this author
Reference
- 1 Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001; 98: 280–286.
- 2 Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet 2000; 356: 223–224.
- 3 Tokuhira M, Hanzawa K, Watanabe R, et al. Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report. J Hematol Oncol 2009; 30: 27–32.
- 4 Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol 2004; 24: 1165–74.
- 5 Sohani AR, Ferry JA, Chang PS, Abramson JS. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma During Therapy With Alemtuzumab for T-Cell Prolymphocytic Leukemia. J Clin Oncol. 2010; 28: 69–72.
- 6 Kuwahara Y, Hirata A, Miwa H, Munakata S, Ueda S, Kanakura Y, Maruno M, Hongyo T, Nomura T, Aozasa K. Epstein-Barr Virus Associated B-Cell Lymphoma of Brain Developing in Myelodysplastic Syndrome With c-kit Mutation (Try-557 → Stop). Am J Hematol 2000; 65: 234–238.
- 7 Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood 1996; 87: 4531–4537.
- 8 Pittaluga S, Wilson WH, Jaffe ES. Lymphomatoid granulomatosis. In: SH Swerdlow, E Campo, NL Harris, et al, eds. WHO Classification of Tumorous of Haematopoietic and Lymphoid Tissues, 4 edn. Lyon, France: International Agency for Research on Cancer; 2008: 247–249.
